Sztanek, F.; Tóth, L.I.; Pető, A.; Hernyák, M.; Diószegi, Á.; Harangi, M.
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines 2024, 12, 1320.
https://doi.org/10.3390/biomedicines12061320
AMA Style
Sztanek F, Tóth LI, Pető A, Hernyák M, Diószegi Á, Harangi M.
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines. 2024; 12(6):1320.
https://doi.org/10.3390/biomedicines12061320
Chicago/Turabian Style
Sztanek, Ferenc, László Imre Tóth, Attila Pető, Marcell Hernyák, Ágnes Diószegi, and Mariann Harangi.
2024. "New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists" Biomedicines 12, no. 6: 1320.
https://doi.org/10.3390/biomedicines12061320
APA Style
Sztanek, F., Tóth, L. I., Pető, A., Hernyák, M., Diószegi, Á., & Harangi, M.
(2024). New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines, 12(6), 1320.
https://doi.org/10.3390/biomedicines12061320